NCT01533389View on ClinicalTrials.gov

Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

August 31, 2012

Conditions
Ureteral Stone
Interventions
DRUG

Silodosin

"Drug: silodosin dosage form : capsule dosage : placebo 4mg\*2 (8mg) frequency and duration : QD, 4weeks~Arms: Placebo"

DRUG

Placebo

dosage form : capsule dosage : placebo 4mg\*2 (8mg) frequency and duration : QD, 4weeks

Trial Locations (5)

410-719

NHIC Ilsan Hospital, Goyang-si

412-270

Myongji Hospital, Goyang-si

110-746

Kangbuk Samsung Medical Center, Seoul

139-707

Inje Univ. Sanggye Paik Hospital, Seoul

139-711

Eulji General Hospital, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical
All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY